Tus kws kho mob
2019 September Provider Press
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 26, 2019
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 2681 - 2690 ntawm 4139
Tus kws kho mob
QP71-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Vascepa
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 14, 2019
Tus kws kho mob
QP70-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Antifungal Agents
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 14, 2019
Tus kws kho mob
QP69-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Riluzole
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 14, 2019
Tus kws kho mob
QP72-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Hemophilia VIII and IX Extended Half-Life Products
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 14, 2019
Tus kws kho mob
P54-19 Precertification for Commercial Inpatient Admissions Effective September 1, 2019
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 01, 2019
Tus kws kho mob
P54R1-19 Update: Precertification for Commercial Inpatient Admissions
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 01, 2019
Tus kws kho mob
P60-19 New Reimbursement Policy for Bundled Services
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 01, 2019
Tus kws kho mob
P65-19 Minnesota Health Care Programs (MHCP) Reimbursement Policy Updates
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 01, 2019
Tus kws kho mob
P62-19 New Medical, Medical Drug and Behavioral Health Policy Management Updates for Commercial Lines of Business – Effective September 30, 2019
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 01, 2019